GlobeNewswire 

Cellebrite Announces Innovative Case-Closing Technology; Raising the Bar for Modern Investigations

Building on established “Collect and Review” Solutions, UFED Ultra brings new level of excellence to digital forensics

Cellebrite Announces Innovative Case-Closing Technology; Raising the Bar for Modern Investigations
Ambrx Appoints Jared Kelly as General Counsel

SAN DIEGO, June 05, 2023 (GLOBE NEWSWIRE) -- Ambrx Biopharma Inc., or Ambrx (NASDAQ: AMAM), today announced the appointment of Jared Kelly as Senior Vice President, General Counsel and Corporate Secretary. After...

Ambrx Appoints Jared Kelly as General Counsel
ARHT's Live Hologram CAPSULE Technology Featured At Augmented World Expo

TORONTO, June 05, 2023 (GLOBE NEWSWIRE) -- ARHT Media Inc. ("ARHT" or "the Company") (TSXV:ART), (OTCQB:ARHTF) the global leader in the development, production and distribution of high-quality, low latency hologram and...

ARHT's Live Hologram CAPSULE Technology Featured At Augmented World Expo
Enlight to Supply Renewable Energy to Amdocs

TEL AVIV, Israel, June 05, 2023 (GLOBE NEWSWIRE) -- Enlight Renewable Energy (“Enlight”) (NASDAQ: ENLT), a leading global renewable energy platform, has entered into a corporate power purchase agreement (“PPA”) with...

Enlight to Supply Renewable Energy to Amdocs
New Research Highlights 'Transformation' of B2B Marketing in U.S. and Europe

-Among findings: digital natives are changing buying behaviors; ‘consumerization’ of B2B is accelerating; analytics and data utilization improve; AI will have a growing impact on thought leadership, content & creative...

New Research Highlights 'Transformation' of B2B Marketing in U.S. and Europe
Surrozen Publishes Study in Nature Communications Demonstrating the Promise of a Fzd4 Wnt Antibody in Treating Ischemic Stroke

In a preclinical model of ischemic stroke, systemic delivery of a selective Fzd4 Wnt antibody strongly reduced blood-brain-barrier leakage, death of surrounding brain tissue, tissue swelling, while improving neurologic...

Surrozen Publishes Study in Nature Communications Demonstrating the Promise of a Fzd4 Wnt Antibody in Treating Ischemic Stroke
Tarsus to Present at the Jefferies Global Healthcare Conference

IRVINE, Calif., June 05, 2023 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients,...

Tarsus to Present at the Jefferies Global Healthcare Conference
eGenesis Presents New Data on Long-Term Survival in Preclinical Kidney Xenotransplantation at American Transplant Congress 2023

Additional presentations highlight new findings on xenotransplantation graft rejection, providing potential methods to predict and improve future clinical outcomes

eGenesis Presents New Data on Long-Term Survival in Preclinical Kidney Xenotransplantation at American Transplant Congress 2023
Gaia Announces Participation in Water Tower Research Fireside Chat Series on June 13th at 2:00 p.m. ET

BOULDER, Colo., June 05, 2023 (GLOBE NEWSWIRE) -- Gaia, Inc. (NASDAQ: GAIA) (“Gaia” and/or the “Company”), a conscious media and community company, announced that CFO Paul Tarell will participate in the Water Tower...

Gaia Announces Participation in Water Tower Research Fireside Chat Series on June 13th at 2:00 p.m. ET
Real Good Foods Announces Launch of NEW Low Carbohydrate, High Protein Burrito Platform into the Refrigerated Entrée Category

CHERRY HILL, N.J., June 05, 2023 (GLOBE NEWSWIRE) -- The Real Good Food Company, Inc. (Nasdaq: RGF) (“Real Good Foods” or the “Company”), a leading health and wellness frozen food company, today announced the launch of their new cheesy burritos loaded with chunks of chicken breast and made with a proprietary low carb tortilla—available in the Club channel today, and coming to grocery stores in the coming months. Real Good Foods’ burritos are made us...

Real Good Foods Announces Launch of NEW Low Carbohydrate, High Protein Burrito Platform into the Refrigerated Entrée Category
Latin Metals Inc. Expands Copper Exploration Footprint with Acquisition of Solario Copper Project, Argentina

VANCOUVER, British Columbia, June 05, 2023 (GLOBE NEWSWIRE) -- Latin Metals Inc. (“Latin Metals” or the “Company”) - (TSXV: LMS)(OTCQB: LMSQF) a leading mineral exploration company in South America, announces that it has...

Latin Metals Inc. Expands Copper Exploration Footprint with Acquisition of Solario Copper Project, Argentina
Aemetis Biogas Achieves Revenue Milestones by Generating Federal RINs and Filing California LCFS Pathway to Begin RNG Revenues in June 2023

Renewable natural gas stored underground during Q4 2022 through Q2 2023 scheduled to begin generating revenues in June 2023; Positive cash flow from biogas expected in Q3 2023 CUPERTINO, CA, June 05, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Aemetis, Inc. (NASDAQ: AMTX), a renewable natural gas and renewable fuels company focused on negative carbon intensity products, announced today that its Aemetis Biogas subsidiary generated federal D3 Renewable Identification Numbers (D3 RI...

Aemetis Biogas Achieves Revenue Milestones by Generating Federal RINs and Filing California LCFS Pathway to Begin RNG Revenues in June 2023
Fairfax Financial Partners With Kennedy Wilson to Acquire Loan Portfolio From Pacific Western Bank, Makes Additional Equity Investment in Kennedy Wilson

(Unless otherwise provided herein, all dollar amounts in this announcement are expressed in U.S. dollars.)

Fairfax Financial Partners With Kennedy Wilson to Acquire Loan Portfolio From Pacific Western Bank, Makes Additional Equity Investment in Kennedy Wilson
Candel Therapeutics to Participate in the 2023 Jefferies Healthcare Conference

NEEDHAM, Mass., June 05, 2023 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing viral immunotherapies to help patients...

Candel Therapeutics to Participate in the 2023 Jefferies Healthcare Conference
NowVertical Group Announces Sasha Grujicic as CEO, Board Appointments and Participation in TSX Technology Investor Day

TORONTO, June 05, 2023 (GLOBE NEWSWIRE) -- NowVertical Group Inc. (TSX-V: NOW) (OTCQB: NOWVF) (the “Company”), a global big data analytics software and services company, further to its release on May 30, 2023, is pleased...

NowVertical Group Announces Sasha Grujicic as CEO, Board Appointments and Participation in TSX Technology Investor Day
Timber Pharmaceuticals Announces FDA Grant of CARC Waiver for TMB-001

- Phase 3 ASCEND study of TMB-001 (topical isotretinoin) for the treatment of congenital ichthyosis is 70% enrolled -

Timber Pharmaceuticals Announces FDA Grant of CARC Waiver for TMB-001
Carina Biotech Appoints Two New U.S. Based Biotechnology Executives to the Board of Directors

ADELAIDE, Australia, June 05, 2023 (GLOBE NEWSWIRE) -- Carina Biotech (Carina), a cell therapy immuno-oncology company, today announced the appointment of Michael S. Wyzga, M.B.A., and Remus Vezan M.D., Ph.D., to its...

Carina Biotech Appoints Two New U.S. Based Biotechnology Executives to the Board of Directors
Erayak Power Solution Group Inc. to Present at the Virtual BetterInvesting National Convention

Wenzhou, China, June 05, 2023 (GLOBE NEWSWIRE) -- Erayak Power Solution Group Inc. ("Erayak" or the "Company") (Nasdaq: RAYA), a leading manufacturer, designer, and exporter of high-quality products in the power supply...

Erayak Power Solution Group Inc. to Present at the Virtual BetterInvesting National Convention
Portage Biotech Reports Updated Interim Data for Lead iNKT Engager, PORT-2, in a Phase 1/2 Trial for the Treatment of Advanced Melanoma and Metastatic Non-Small Cell Lung Cancer at the 2023 American Society for Clinical Oncology (ASCO) Annual Meeting

Interim data presented at ASCO show early evidence of single agent activity with meaningful reduction of several target lesionsBased on the favorable safety and tolerability data at all doses tested to date, the Company...

Portage Biotech Reports Updated Interim Data for Lead iNKT Engager, PORT-2, in a Phase 1/2 Trial for the Treatment of Advanced Melanoma and Metastatic Non-Small Cell Lung Cancer at the 2023 American Society for Clinical Oncology (ASCO) Annual Meeting
Revolo Biotherapeutics Presents New Data for '1805 in Inflammatory Bowel Disease and Rheumatoid Arthritis at the 5th Treg Directed Therapies Summit

Data demonstrates the potential of ‘1805 to reset the immune system through its unique mechanism of action across various autoimmune diseases, including inflammatory bowel disease and rheumatoid arthritis

Revolo Biotherapeutics Presents New Data for '1805 in Inflammatory Bowel Disease and Rheumatoid Arthritis at the 5th Treg Directed Therapies Summit
Imbria Pharmaceuticals Completes Enrollment in Phase 2 IMPROVE-HCM Trial of Ninerafaxstat in Patients with Non-obstructive Hypertrophic Cardiomyopathy

– Enrollment exceeded expectations, thus highlighting the large unmet need in non-obstructive hypertrophic cardiomyopathy –

Imbria Pharmaceuticals Completes Enrollment in Phase 2 IMPROVE-HCM Trial of Ninerafaxstat in Patients with Non-obstructive Hypertrophic Cardiomyopathy
WSP Completes the Acquisition of Calibre

MONTREAL, June 05, 2023 (GLOBE NEWSWIRE) -- WSP Global Inc. (TSX: WSP) (“WSP” or the “Corporation”) is pleased to announce that it has completed the acquisition of Calibre Professional Services One Pty Ltd (“Calibre”),...

WSP Completes the Acquisition of Calibre
Inspire Medical Systems, Inc. Announces Events at SLEEP 2023, the 37th Annual Meeting of the Associated Professional Sleep Societies

MINNEAPOLIS, June 05, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive...

Inspire Medical Systems, Inc. Announces Events at SLEEP 2023, the 37th Annual Meeting of the Associated Professional Sleep Societies
Taysha Gene Therapies Announces First Patient Dosed with TSHA-102 in the REVEAL Phase 1/2 Trial Under Investigation for the Treatment of Rett Syndrome

The Phase 1/2 REVEAL trial is a first-in-human, randomized, dose-escalation and dose-expansion study evaluating the safety and preliminary efficacy of TSHA-102 in adults with Rett syndrome

Taysha Gene Therapies Announces First Patient Dosed with TSHA-102 in the REVEAL Phase 1/2 Trial Under Investigation for the Treatment of Rett Syndrome
IN8bio Announces Positive INB-200 Phase 1 Data Update in Glioblastoma at the 2023 ASCO Annual Meeting

100% of treated patients (n=8) to date have exceeded historical median progression-free survival, with two patients that received three doses remaining progression-free at 23.5 and 19.4 months, respectively.INB-200...

IN8bio Announces Positive INB-200 Phase 1 Data Update in Glioblastoma at the 2023 ASCO Annual Meeting
NovelMed Phase I Clinical Trial Shows Inhibition of the Alternative Pathway and Preservation of the Classical Pathway – A Long-Acting Anti-Properdin Monoclonal Antibody NM3086 for PNH Patients

Phase I Clinical Trial in healthy subjects shows that NM3086 was safe and well tolerated at all doses (0.1 to 20 mg/kg) in six cohorts.Total AP inhibition was achieved through all cohorts and the duration of alternative...

NovelMed Phase I Clinical Trial Shows Inhibition of the Alternative Pathway and Preservation of the Classical Pathway – A Long-Acting Anti-Properdin Monoclonal Antibody NM3086 for PNH Patients
Enterin Announces the Start of a First-in-Human Study of ENT-03 in Obesity and Type 2 Diabetes

PHILADELPHIA, June 05, 2023 (GLOBE NEWSWIRE) -- Enterin Inc., a privately held, Philadelphia-based, clinical-stage biopharmaceutical company pioneering novel treatments for neurodegenerative and metabolic diseases, today...

Enterin Announces the Start of a First-in-Human Study of ENT-03 in Obesity and Type 2 Diabetes
Atreca Presents Data from Ongoing Phase 1b Study of ATRC-101 in Patients with Select Advanced Solid Tumors during Oral Abstract Session at the ASCO 2023 Annual Meeting

Clinical activity observed in multiple tumor types; longer progression-free survival observed in patients with high target expression; ATRC-101 continues to be well-tolerated

Atreca Presents Data from Ongoing Phase 1b Study of ATRC-101 in Patients with Select Advanced Solid Tumors during Oral Abstract Session at the ASCO 2023 Annual Meeting
Concrete Pumping Holdings Upsizes Asset-Based Lending Facility to $225 Million

PNC Joins Wells Fargo and JPMorgan in Lending Facility  ABL Credit Agreement maturity extended for 5 years to June 1, 2028

Concrete Pumping Holdings Upsizes Asset-Based Lending Facility to $225 Million
Digital Trade and Supply Chain Finance Provider Appoints Marina Narganes to Leadership Team

Industry expert joins as Triterras continues to scale its Supply Chain Finance & Working Capital Solutions

Digital Trade and Supply Chain Finance Provider Appoints Marina Narganes to Leadership Team
NKGen Biotech Announces SNK01 Preclinical and Phase I/IIa Clinical Data Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

SANTA ANA, Calif., June 05, 2023 (GLOBE NEWSWIRE) -- NKGen Biotech Inc. (NKGen), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK...

NKGen Biotech Announces SNK01 Preclinical and Phase I/IIa Clinical Data Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
Amolyt Pharma Announces Initiation of Phase 1 Clinical Trial of Peptide Growth Hormone Receptor Antagonist (GHRA), AZP-3813, for Acromegaly

LYON, France and CAMBRIDGE, Mass., June 05, 2023 (GLOBE NEWSWIRE) -- Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related diseases, today announced the initiation...

Amolyt Pharma Announces Initiation of Phase 1 Clinical Trial of Peptide Growth Hormone Receptor Antagonist (GHRA), AZP-3813, for Acromegaly
Immuneering Completes Dose Escalation in the IMM-1-104 Phase 1 Clinical Trial for RAS-Mutant, Advanced Solid Tumors

- No dose limiting toxicities observed with IMM-1-104 up to 320 mg once daily during the Phase 1a dose escalation portion of ongoing clinical study -

Immuneering Completes Dose Escalation in the IMM-1-104 Phase 1 Clinical Trial for RAS-Mutant, Advanced Solid Tumors
Support for Indigenous Businesses a Pathway to Healing and Growth

72% of Canadians believe Indigenous businesses are important to the creation of sustainable economic opportunity; only one-third claim to be unaware of Indigenous businesses as part of key findings of a Sodexo Survey

Support for Indigenous Businesses a Pathway to Healing and Growth
Mobiv Acquisition Corp Announces Extension of Deadline to Complete Business Combination

Newark, Delaware, June 05, 2023 (GLOBE NEWSWIRE) -- Mobiv Acquisition Corp (Nasdaq: MOBVU, MOBV, MOBVW) (the “Company”), a special purpose acquisition company, announced today that, on June 1, 2023, it notified the...

Mobiv Acquisition Corp Announces Extension of Deadline to Complete Business Combination
Replimune Appoints Veleka R. Peeples-Dyer to its Board of Directors

WOBURN, Mass., June 05, 2023 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of a novel portfolio of tumor-directed oncolytic immunotherapies,...

Replimune Appoints Veleka R. Peeples-Dyer to its Board of Directors
Rani Therapeutics and Celltrion Expand Partnership to Include Adalimumab Biosimilar for RT-105

This is the second deal announced between Rani and Celltrion, building upon a previously announced partnership for ustekinumab biosimilar for RT-111

Rani Therapeutics and Celltrion Expand Partnership to Include Adalimumab Biosimilar for RT-105
Aspira Women's Health Appoints Dr. Winfred Parnell to its Board of Directors

AUSTIN, Texas, June 05, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools,...

Aspira Women's Health Appoints Dr. Winfred Parnell to its Board of Directors
Vor Bio to Participate in the Goldman Sachs Healthcare Conference

CAMBRIDGE, Mass., June 05, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will present and host in-person 1x1 investor meetings at the Goldman Sachs 44th Annual...

Vor Bio to Participate in the Goldman Sachs Healthcare Conference
InnovAge Announces Participation at the 44th Annual Goldman Sachs Global Healthcare Conference

DENVER, June 05, 2023 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail seniors through the Program of...

InnovAge Announces Participation at the 44th Annual Goldman Sachs Global Healthcare Conference
Community Association Services of Indiana Hosts Free Webinar On Unpaid Dues And Collection Processes For Managed Community Board Members

CARMEL, Ind., June 05, 2023 (GLOBE NEWSWIRE) -- Associa Community Association Services of Indiana (CASI)  invites you to attend its upcoming board education seminar. This free educational event will review important...

Community Association Services of Indiana Hosts Free Webinar On Unpaid Dues And Collection Processes For Managed Community Board Members
Cue Biopharma to Present at the Jefferies 2023 Global Healthcare Conference

BOSTON, June 05, 2023 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and modulate disease-specific...

Cue Biopharma to Present at the Jefferies 2023 Global Healthcare Conference
ASML reports transactions under its current share buyback program

ASML reports transactions under its current share buyback program

ASML reports transactions under its current share buyback program
Chimeric Therapeutics To Attend BIO International Convention

SYDNEY, Australia and NEW YORK, June 05, 2023 (GLOBE NEWSWIRE) -- Chimeric Therapeutics (ASX: CHM) (“Chimeric Therapeutics”, “Chimeric” or the “Company”), a clinical-stage cell therapy company and an Australian leader in...

Chimeric Therapeutics To Attend BIO International Convention
Toronto Transit Commission awards NFI contract for up to 621 New Flyer battery-electric heavy-duty transit buses

WINNIPEG, Manitoba, June 05, 2023 (GLOBE NEWSWIRE) -- (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (“NFI”), a leading independent bus and coach manufacturer and a leader in electric mass mobility solutions, today announced that the Toronto Transit Commission (“TTC”) has awarded its subsidiary New Flyer Industries Canada ULC (“New Flyer”) a new five-year contract for 40-foot battery-electric buses. The total contract includes a firm order f...

Toronto Transit Commission awards NFI contract for up to 621 New Flyer battery-electric heavy-duty transit buses
EVERMIND Evaluating Public Offering; Unleashing the Power of Cognitive Wellness Through Innovative, Functional Food and Beverage Products

LANCASTER, PA, June 05, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- EVERMIND Inc. (“EVERMIND”), a pioneering consumer products platform dedicated to cognitive health, has announced that it is evaluating a...

EVERMIND Evaluating Public Offering; Unleashing the Power of Cognitive Wellness Through Innovative, Functional Food and Beverage Products
MiNK Therapeutics Announces Virtual Annual Shareholders Meeting

NEW YORK, June 05, 2023 (GLOBE NEWSWIRE) -- MiNK Therapeutics (Nasdaq: INKT), a clinical-stage biopharmaceutical company specializing in the discovery, development, and commercialization of allogeneic, off-the-shelf,...

MiNK Therapeutics Announces Virtual Annual Shareholders Meeting
Prepay Nation and Safaricom Ethiopia team up to offer international mobile top-up to Ethiopians living abroad

Partnership to boost Ethiopian telecom industry growth of cross-border transactions

Prepay Nation and Safaricom Ethiopia team up to offer international mobile top-up to Ethiopians living abroad
Alpha Lithium Responds to Tecpetrol Announcement of Intention to Make Below Market Tender Offer

VANCOUVER, British Columbia, June 05, 2023 (GLOBE NEWSWIRE) -- Alpha Lithium Corporation (NEO: ALLI) (OTC: APHLF) (German WKN: A3CUW1) (“Alpha Lithium” or the “Company”) today responded to the June 2, 2023 announcement...

Alpha Lithium Responds to Tecpetrol Announcement of Intention to Make Below Market Tender Offer
EnviroGold Global Closes $2.15M Financing

TORONTO, June 05, 2023 (GLOBE NEWSWIRE) -- EnviroGold Global Limited (CSE: NVRO | OTCQB: ESGLF | FSE: YGK) (“EnviroGold Global” or the “Company”), a Clean Technology Company accelerating the world’s transition to a...

EnviroGold Global Closes $2.15M Financing
Lycia Therapeutics to Present at Jefferies Healthcare Conference

SOUTH SAN FRANCISCO, Calif., June 05, 2023 (GLOBE NEWSWIRE) -- Lycia Therapeutics, Inc., a leader in extracellular protein degradation, today announced that Aetna Wun Trombley, Ph.D., President and Chief Executive...

Lycia Therapeutics to Present at Jefferies Healthcare Conference
BiondVax signs exclusive license agreement for development and commercialization of a novel anti-IL-17 antibody for treatment of autoimmune and inflammatory diseases including psoriasis

Broad-based collaboration with Max Planck and University Medical Center Gottingen yields attractive anti-IL-17 VHH antibodies (NanoAbs); includes exclusive worldwide license for all potential indications, beginning with...

BiondVax signs exclusive license agreement for development and commercialization of a novel anti-IL-17 antibody for treatment of autoimmune and inflammatory diseases including psoriasis
GDS Announces Results of Annual General Meeting of Shareholders and of Additional Meetings of Shareholders

SHANGHAI, China, June 05, 2023 (GLOBE NEWSWIRE) -- GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China and...

GDS Announces Results of Annual General Meeting of Shareholders and of Additional Meetings of Shareholders
VICTORY LAUNCHES EXPLORATION PROGRAM AT ITS GEORGIA LAKE LITHIUM PROJECT IN ONTARIO

VANCOUVER, BC, CANADA, June 05, 2023 (GLOBE NEWSWIRE) --

VICTORY LAUNCHES EXPLORATION PROGRAM AT ITS GEORGIA LAKE LITHIUM PROJECT IN ONTARIO
5E Advanced Materials Appoints Susan Seilheimer Brennan to the Board of Directors

HESPERIA, Calif., June 05, 2023 (GLOBE NEWSWIRE) -- 5E Advanced Materials, Inc. (Nasdaq: FEAM) (ASX: 5EA) (5E or the Company), a boron and lithium company with U.S. government Critical Infrastructure designation for its...

5E Advanced Materials Appoints Susan Seilheimer Brennan to the Board of Directors
Osisko Mining Provides Corporate Update

TORONTO, June 05, 2023 (GLOBE NEWSWIRE) -- Osisko Mining Inc. (TSX:OSK. “Osisko” or the “Corporation“) would like to provide the following update on the ongoing forest fire situation affecting the communities in Abitibi...

Osisko Mining Provides Corporate Update
RS BioTherapeutics Appoints Michelle L. Shuffett, MD as SVP of Medical and Scientific Affairs

CUMBERLAND, Md., June 05, 2023 (GLOBE NEWSWIRE) -- RS BioTherapeutics, whose mission is to harness the therapeutic power of cannabinoids in the research, development, and commercialization of life changing medications,...

RS BioTherapeutics Appoints Michelle L. Shuffett, MD as SVP of Medical and Scientific Affairs
Akero Therapeutics' Phase 2b SYMMETRY Cohort D Study Met Safety & Tolerability Endpoints and Showed Adding EFX to GLP-1 Therapy Significantly Improved Non-Invasive Markers of NASH-Related Disease

Patients treated with EFX for 12 weeks combined with GLP-1 achieved a 65% relative reduction in liver fat, compared to a 10% relative reduction for GLP-1 alone

Akero Therapeutics' Phase 2b SYMMETRY Cohort D Study Met Safety & Tolerability Endpoints and Showed Adding EFX to GLP-1 Therapy Significantly Improved Non-Invasive Markers of NASH-Related Disease
Foghorn Therapeutics Announces FDA Has Lifted Clinical Hold on Phase 1 Study of FHD-286 in Relapsed and/or Refractory AML/MDS Patients

- Plan to Initiate a Phase 1 Study of FHD-286 in Combination with Decitabine or Cytarabine in Relapsed and/or Refractory AML Patients in Q3’2023

Foghorn Therapeutics Announces FDA Has Lifted Clinical Hold on Phase 1 Study of FHD-286 in Relapsed and/or Refractory AML/MDS Patients
Akoustis to Exhibit and Present at the IEEE MTT-S International Microwave Symposium June 13-15

Akoustis to Present at WSP Workshop, Industry Showcase, IMS Technical Session, and Interactive ForumBooth Demonstrations Include Wi-Fi 6E & 7, Medical, and Automotive Filter Solutions including BAW Filters, SAW...

Akoustis to Exhibit and Present at the IEEE MTT-S International Microwave Symposium June 13-15
Grace Breeding Announces Results from its NFT Bio-Fertilizer Field Trial in Corn Plants Conducted in Brazil Confirming Previous Greenhouse Results

-Results of the Brazilian field trials in corn plants cultivated with NFT were encouraging and confirmed the preliminary early-stage results in the greenhouse, showing greater efficiency in the use of nitrogen and water...

Grace Breeding Announces Results from its NFT Bio-Fertilizer Field Trial in Corn Plants Conducted in Brazil Confirming Previous Greenhouse Results
Krystal Biotech to Present at Upcoming Investor Conferences

PITTSBURGH, June 05, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) a biotechnology company focused on developing and commercializing genetic medicines for patients with rare diseases,...

Krystal Biotech to Present at Upcoming Investor Conferences
Diversified Royalty Corp. Announces Completion of BMO Acquisition of Air MILES Reward Program Business and June 2023 Cash Dividend

VANCOUVER, British Columbia, June 05, 2023 (GLOBE NEWSWIRE) -- Diversified Royalty Corp. (TSX: DIV and DIV.DB.A) (the “Corporation” or “DIV”) is pleased to announce that on June 1, 2023 the Bank of Montreal (“BMO”)...

Diversified Royalty Corp. Announces Completion of BMO Acquisition of Air MILES Reward Program Business and June 2023 Cash Dividend
Hammerhead Energy Inc. announces results of its substantial issuer bid

CALGARY, Alberta, June 05, 2023 (GLOBE NEWSWIRE) -- Hammerhead Energy Inc. ("Hammerhead" or "HEI") (TSX: HHRS, HHRS.WT ; NASDAQ: HHRS, HHRSW) announces the results of its substantial issuer bid (the "Offer"), pursuant to...

Hammerhead Energy Inc. announces results of its substantial issuer bid
Interface Launches AI-based Intelligent Voice-down System

Versatile solution helps to deter a wide range of security threats and performs operational tasks for consumer-facing businesses.

Interface Launches AI-based Intelligent Voice-down System
NewAmsterdam Pharma Announces Positive Topline Results from Phase 2b Dose-Finding Trial Evaluating Obicetrapib in Japanese Patients

-- Achieved Primary Endpoint with Statistically Significant 45.8% Median Reduction in LDL-C (p < 0.0001) in patients treated with 10mg obicetrapib--

NewAmsterdam Pharma Announces Positive Topline Results from Phase 2b Dose-Finding Trial Evaluating Obicetrapib in Japanese Patients
Ocugen, Inc. Announces Business Advisory Board

MALVERN, Pa., June 05, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies,...

Ocugen, Inc. Announces Business Advisory Board
Ractigen Therapeutics Announces Dosing of First Patient in First in Human Trial of RAG-17 for the Treatment of SOD1-ALS

Study aims to evaluate the safety and feasibility of RAG-17 in human patients and clinically validate Ractigen’s proprietary CNS delivery platform enabling new oligonucleotides therapeutics in the CNS

Ractigen Therapeutics Announces Dosing of First Patient in First in Human Trial of RAG-17 for the Treatment of SOD1-ALS
Renalytix to Report Third Quarter Fiscal Year 2023 Financial Results on June 9

LONDON and SALT LAKE CITY, June 05, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) will report its third quarter fiscal year 2023 financial results on Friday, June 9, 2023, before market open. The...

Renalytix to Report Third Quarter Fiscal Year 2023 Financial Results on June 9
Allakos Announces Upcoming Presentation on Lirentelimab and AK006 Mast Cell Inhibition at the European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress 2023

SAN CARLOS, Calif., June 05, 2023 (GLOBE NEWSWIRE) -- Allakos Inc. (Nasdaq: ALLK), a clinical-stage biotechnology company developing therapeutics which target immunomodulatory receptors present on immune effector cells...

Allakos Announces Upcoming Presentation on Lirentelimab and AK006 Mast Cell Inhibition at the European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress 2023
Arvinas to Participate in Upcoming Investor Conferences

NEW HAVEN, Conn., June 05, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that...

Arvinas to Participate in Upcoming Investor Conferences
American Institutes for Research Experts to Present at AcademyHealth Annual Research Meeting

Arlington, Va., June 05, 2023 (GLOBE NEWSWIRE) -- Arlington, Va. – Health experts from the American Institutes for Research (AIR) will present and share findings at AcademyHealth’s 2023 Annual Research Meeting (ARM),...

American Institutes for Research Experts to Present at AcademyHealth Annual Research Meeting
Alamos Gold Declares Quarterly Dividend

TORONTO, June 05, 2023 (GLOBE NEWSWIRE) -- Alamos Gold Inc. (TSX:AGI; NYSE:AGI) (“Alamos” or the “Company”) today announced that the Company’s Board of Directors has declared a quarterly dividend of US$0.025 per common...

Alamos Gold Declares Quarterly Dividend
Vision Energy Concludes Pre-FEED Study

JERSEY CITY, N.J., June 05, 2023 (GLOBE NEWSWIRE) -- Vision Energy Corporation (OTC:VENG) (“Vision Energy” or the “Company”) is pleased to announce it has concluded the pre-FEED study for all Phase 1 Green Ammonia...

Vision Energy Concludes Pre-FEED Study
Prenetics Announces First Quarter 2023 Financial Results

HONG KONG, June 05, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading genomics and precision oncology company, today announced financial results for the first...

Prenetics Announces First Quarter 2023 Financial Results
Bofu Agence Marketing Obtains The CONCILIVI Seal

SAINT-JÉRÔME, Quebec, June 05, 2023 (GLOBE NEWSWIRE) -- We are proud to announce that Bofu Agence Marketing recently obtained the CONCILIVI seal, which recognizes companies advocating better work-family balance for its...

Bofu Agence Marketing Obtains The CONCILIVI Seal
Passage Bio to Present at Goldman Sachs 44th Annual Global Healthcare Conference

PHILADELPHIA, June 05, 2023 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical stage genetic medicines company focused on developing transformative therapies for central nervous system (CNS) disorders,...

Passage Bio to Present at Goldman Sachs 44th Annual Global Healthcare Conference
ANeuroTech receives IND approval from the FDA for pivotal Phase IIIB trial of adjunctive anti-depression drug, ANT-01

ANeuroTechreceives IND approval from the FDA for pivotal Phase IIIB trial of adjunctive anti-depression drug, ANT-01

ANeuroTech receives IND approval from the FDA for pivotal Phase IIIB trial of adjunctive anti-depression drug, ANT-01
Immodulon Appoints Experienced Clinical and Medical Affairs Executive Josefine Roemmler-Zehrer, MD, Associate Professor, as Chief Medical Officer

Josefine Roemmler-Zehrer, former Medical Director at Ipsen & Celgene, brings broad global clinical and medical affairs expertiseAdding further oncology experience to Immodulon’s leadership team as the company prepares...

Immodulon Appoints Experienced Clinical and Medical Affairs Executive Josefine Roemmler-Zehrer, MD, Associate Professor, as Chief Medical Officer
Synlogic Announces Initiation of Synpheny-3 Global, Pivotal Phase 3 Study Evaluating SYNB1934 for Treatment of Phenylketonuria

Registrational study designed to support BLA submission of first-in-class biotherapeutic

Synlogic Announces Initiation of Synpheny-3 Global, Pivotal Phase 3 Study Evaluating SYNB1934 for Treatment of Phenylketonuria
Brookfield Asset Management to Present at the Morgan Stanley US Financials, Payments and CRE Conference

BROOKFIELD, NEWS, June 05, 2023 (GLOBE NEWSWIRE) -- Brookfield Asset Management Ltd. (NYSE: BAM, TSX: BAM) announced that Bruce Flatt, Chief Executive Officer, is scheduled to deliver the keynote presentation at the...

Brookfield Asset Management to Present at the Morgan Stanley US Financials, Payments and CRE Conference
BullFrog AI Strengthens Capabilities of its AI Platform through Expansion of Licensing Agreement with Johns Hopkins Applied Physics Laboratory

GAITHERSBURG, Md., June 05, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("BullFrog AI" or the "Company"), a digital technology company using machine learning to usher in a new era of...

BullFrog AI Strengthens Capabilities of its AI Platform through Expansion of Licensing Agreement with Johns Hopkins Applied Physics Laboratory
SpringWorks Therapeutics Announces PDUFA Date Extension for Nirogacestat NDA

FDA Extending PDUFA Date by Three Months to Allow More Time to Complete Their Review; New PDUFA Date Set to November 27, 2023

SpringWorks Therapeutics Announces PDUFA Date Extension for Nirogacestat NDA
Wesdome Gold Mines Announces Appointment of Anthea Bath as President and CEO

TORONTO, June 05, 2023 (GLOBE NEWSWIRE) -- Wesdome Gold Mines Ltd. (TSX: WDO) (“Wesdome” or the “Company”) is pleased to announce the appointment of Anthea Bath as President and Chief Executive Officer effective July 1,...

Wesdome Gold Mines Announces Appointment of Anthea Bath as President and CEO
Park Hotels & Resorts Inc. Announces Cessation of Payment on $725 Million Non-Recourse CMBS Loan Secured By Two of Its San Francisco Hotels

TYSONS, Va., June 05, 2023 (GLOBE NEWSWIRE) -- Park Hotels & Resorts Inc. (“Park” or the “Company”) (NYSE:PK) today announced that, starting in June, it ceased making payments toward the $725 million non-recourse...

Park Hotels & Resorts Inc. Announces Cessation of Payment on $725 Million Non-Recourse CMBS Loan Secured By Two of Its San Francisco Hotels
ISS Appears to Rely on MindMed's False and Misleading Statements to Justify the Company's Abysmal Performance; Seemingly Ignores MindMed's Apparent Disregard of Patient Safety

ISS Dismissed 47% Stock Price Drop Following September 2022 Financing as In Line with “Sectoral Trends”, in a Baffling Lack of Critical Analysis and Seemingly in Opposition to the Factual Circumstances

ISS Appears to Rely on MindMed's False and Misleading Statements to Justify the Company's Abysmal Performance; Seemingly Ignores MindMed's Apparent Disregard of Patient Safety
Digital Health Startup Accelerator Kilo Health Launches a New Product – Lifestyle Design and Management App Greatness

VILNIUS, Lithuania, June 05, 2023 (GLOBE NEWSWIRE) -- Digital health company Kilo Health has launched its newest product – habit tracking and lifestyle management app Greatness. The product is the latest edition in the...

Digital Health Startup Accelerator Kilo Health Launches a New Product – Lifestyle Design and Management App Greatness
Fusion Fuel Green Hosts First Quarter 2023 Investor Update

SABUGO, Portugal, June 05, 2023 (GLOBE NEWSWIRE) -- Fusion Fuel Green plc (NASDAQ: HTOO) ("Fusion Fuel"), an emerging leader in the green hydrogen sector, today announced financial results for the first quarter ended...

Fusion Fuel Green Hosts First Quarter 2023 Investor Update
ChiMETA unveils world's lightest MR glasses that redefine productivity

Pioneering startup introduces patented virtual keyboard and touch screen for enhanced mixed reality experiences

ChiMETA unveils world's lightest MR glasses that redefine productivity
Willow Creek Partners Launches Platform Company The One 23 Group To Support the Government Services Market

The Platform Serves the Department of Defense, Intelligence, and Federal Civilian Customers

Willow Creek Partners Launches Platform Company The One 23 Group To Support the Government Services Market
PathMaker Neurosystems Receives $200,000 START Award from MassVentures

BOSTON, June 05, 2023 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the treatment of serious neurological...

PathMaker Neurosystems Receives $200,000 START Award from MassVentures
Avoid a Noisy Start to Summer: Allstate Data Shows Automotive Catalytic Converter Theft Rose 60% Last Year

Claims for catalytic converter thefts increased over 1,700% between 2018-2022

Avoid a Noisy Start to Summer: Allstate Data Shows Automotive Catalytic Converter Theft Rose 60% Last Year
Keynes at 140: British Economist Argued Against Printing Money to Finance Deficits

The study’s publication coincides with the famed economist’s 140th birthday.

Keynes at 140: British Economist Argued Against Printing Money to Finance Deficits
Btab Ecommerce Group, Inc. (formerly American Seniors Association Holding Group, Inc.) Announces Name Change and OTC Markets Ticker Symbol Change

Effective at the Open of Market Trading Today, the Company Began Trading as Btab Ecommerce Group, Inc. (OTC: BBTT)

Btab Ecommerce Group, Inc. (formerly American Seniors Association Holding Group, Inc.) Announces Name Change and OTC Markets Ticker Symbol Change
Juanicipio Achieves Commercial Production

VANCOUVER, British Columbia, June 05, 2023 (GLOBE NEWSWIRE) -- MAG Silver Corp. (TSX / NYSE American: MAG) (“MAG” or “MAG Silver”) is pleased to announce that commercial production has been achieved at the Juanicipio...

Juanicipio Achieves Commercial Production
Fusion Fuel Announces Leadership Changes and Key Management Appointments to Support Next Phase of Strategic Growth

SABUGO, Portugal, June 05, 2023 (GLOBE NEWSWIRE) -- Fusion Fuel Green plc (NASDAQ: HTOO) today announced several senior leadership changes to sharpen its strategic focus and seek to unlock long-term growth and...

Fusion Fuel Announces Leadership Changes and Key Management Appointments to Support Next Phase of Strategic Growth
Fusion Fuel Announces Publication of Inaugural ESG Report

SABUGO, Portugal, June 05, 2023 (GLOBE NEWSWIRE) -- Fusion Fuel Green plc (NASDAQ: HTOO) is proud to announce the publication of its inaugural Environmental, Social and Governance (“ESG”) Report and the launch of its new...

Fusion Fuel Announces Publication of Inaugural ESG Report
Samsung Canada puts Canadians in the artist's chair with creative experiences in Toronto and Montreal as part of the Flex Your Design contest

Canadians are invited to create unique case designs for the Samsung Galaxy Z Flip4 at MURAL Festival in Montreal and the Samsung Experience Store in the CF Toronto Eaton Centre

Samsung Canada puts Canadians in the artist's chair with creative experiences in Toronto and Montreal as part of the Flex Your Design contest
Fortuna regrets to report a fatality at its Caylloma Mine in Peru

VANCOUVER, British Columbia, June 05, 2023 (GLOBE NEWSWIRE) -- Fortuna Silver Mines Inc. (NYSE: FSM) (TSX: FVI) regrets to report that a fatality involving a worker employed by a mining contractor occurred at the...

Fortuna regrets to report a fatality at its Caylloma Mine in Peru
ITM Announces €255m Investment Round, Plans to Advance Radiopharmaceutical Pipeline and to Expand Radioisotope Production Capacities

  One of the largest private investment rounds in European biotech to-dateNet proceeds will enhance ITM’s radiopharmaceutical pipeline, bolster commercial infrastructure, expand leading manufacturing capabilities, and enable strategic initiativesITM welcomes Temasek, BlackRock, QIA, Nextech, ATHOS and Carbyne as investorsGarching / Munich, June 5, 2023 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced an equity investmen...

ITM Announces €255m Investment Round, Plans to Advance Radiopharmaceutical Pipeline and to Expand Radioisotope Production Capacities
BIO-key Leverages AWS Partner Network to Build Identity and Access Management (IAM) Solutions in Europe, the Middle East and Africa

WALL, N.J. and MADRID, Spain, June 05, 2023 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of Identity and Access Management (IAM) and Identity-Bound Biometric (IBB) solutions, and...

BIO-key Leverages AWS Partner Network to Build Identity and Access Management (IAM) Solutions in Europe, the Middle East and Africa
VaxEquity and CPI Announces Innovate UK Grant to Accelerate Next Generation RNA Vaccines and Therapeutics

CAMBRIDGE, United Kingdom, June 05, 2023 (GLOBE NEWSWIRE) -- VaxEquity, developing transformative RNA vaccines and therapeutics based on its next generation self-amplifying RNA (saRNA) platform, and CPI, the UK’s leading...

VaxEquity and CPI Announces Innovate UK Grant to Accelerate Next Generation RNA Vaccines and Therapeutics
Kiplin Metals Addresses Activity Surrounding the Cluff Lake Road ("CLR") Uranium Project in Saskatchewan

VANCOUVER, British Columbia, June 05, 2023 (GLOBE NEWSWIRE) -- Kiplin Metals Inc. (TSX-V: KIP) (the “Company” or “Kiplin”) has observed a significant increase in activity surrounding its Cluff Lake Road (CLR) uranium...

Kiplin Metals Addresses Activity Surrounding the Cluff Lake Road ("CLR") Uranium Project in Saskatchewan
ERYTECH announces that Akkadian has initiated proceedings to postpone the vote on the merger with Pherecydes

ERYTECH announces that Akkadian has initiated proceedings to postpone the vote on the merger with Pherecydes

ERYTECH announces that Akkadian has initiated proceedings to postpone the vote on the merger with Pherecydes
CUTERA, INC. (NASDAQ: CUTR) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Cutera, Inc.

Did you lose money on investments in Cutera? If so, please visit Cutera, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.

CUTERA, INC. (NASDAQ: CUTR) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Cutera, Inc.
VIATRIS INC. (NASDAQ: VTRS) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Viatris Inc.

Did you lose money on investments in Viatris? If so, please visit Viatris Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.

VIATRIS INC. (NASDAQ: VTRS) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Viatris Inc.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (NYSE: CRL) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Charles River Laboratories Int

Did you lose money on investments in Charles River? If so, please visit Charles River Laboratories International, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to...

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (NYSE: CRL) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Charles River Laboratories Int
STEM, INC. (NYSE: STEM) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Stem, Inc.

Did you lose money on investments in Stem Inc.? If so, please visit Stem, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.

STEM, INC. (NYSE: STEM) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Stem, Inc.
BEYOND MEAT, INC. (NASDAQ: BYND) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Beyond Meat, Inc.

Did you lose money on investments in Beyond Meat? If so, please visit Beyond Meat Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.

BEYOND MEAT, INC. (NASDAQ: BYND) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Beyond Meat, Inc.
ICAHN ENTERPRISES L.P. (NASDAQ: IEP) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Icahn Enterprises L.P.

Did you lose money on investments in Icahn Enterprises? If so, please visit Icahn Enterprises L.P. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.

ICAHN ENTERPRISES L.P. (NASDAQ: IEP) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Icahn Enterprises L.P.
SPIRIT AEROSYSTEMS HOLDINGS, INC. (NYSE: SPR) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Spirit AeroSystems Holdings, Inc.

Did you lose money on investments in Spirit AeroSystems? If so, please visit Spirit AeroSystems Holdings, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss...

SPIRIT AEROSYSTEMS HOLDINGS, INC. (NYSE: SPR) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Spirit AeroSystems Holdings, Inc.
ADIDAS AG (OTC PINK: ADDDF, ADDYY) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against adidas AG

Did you lose money on investments in adidas? If so, please visit adidas AG Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.

ADIDAS AG (OTC PINK: ADDDF, ADDYY) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against adidas AG
TELEPHONE AND DATA SYSTEMS, INC. (NYSE: TDS) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Telephone and Data Systems, Inc.

Did you lose money on investments in Telephone and Data Systems? If so, please visit Telephone and Data Systems, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to...

TELEPHONE AND DATA SYSTEMS, INC. (NYSE: TDS) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Telephone and Data Systems, Inc.
LIVEPERSON, INC. (NASDAQ: LPSN) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against LivePerson, Inc.

Did you lose money on investments in LivePerson? If so, please visit LivePerson, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.

LIVEPERSON, INC. (NASDAQ: LPSN) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against LivePerson, Inc.
FULCRUM THERAPEUTICS, INC. (NASDAQ: FULC) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Fulcrum Therapeutics, Inc.

Did you lose money on investments in Fulcrum Therapeutics, Inc.? If so, please visit Fulcrum Therapeutics, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to...

FULCRUM THERAPEUTICS, INC. (NASDAQ: FULC) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Fulcrum Therapeutics, Inc.
ALLBIRDS, INC. (NASDAQ: BIRD) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Allbirds, Inc.

Did you lose money on investments in Allbirds? If so, please visit Allbirds, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.

ALLBIRDS, INC. (NASDAQ: BIRD) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Allbirds, Inc.
NUTANIX, INC. (NASDAQ: NTNX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Nutanix, Inc.

Did you lose money on investments in Nutanix? If so, please visit Nutanix, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.

NUTANIX, INC. (NASDAQ: NTNX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Nutanix, Inc.
VERTEX ENERGY, INC. (NASDAQ: VTNR) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Vertex Energy, Inc.

Did you lose money on investments in Vertex Energy, Inc.? If so, please visit Vertex Energy, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.

VERTEX ENERGY, INC. (NASDAQ: VTNR) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Vertex Energy, Inc.
Alpha Transform Holdings Welcomes Wes Levitt as Co-Chief Investment Officer

BRADENTON, FL, June 05, 2023 (GLOBE NEWSWIRE) -- Alpha Transform Holdings, announced today that Wes Levitt, CFA will join the firm as Co-Chief Investment Officer.

Alpha Transform Holdings Welcomes Wes Levitt as Co-Chief Investment Officer
Lleida.net reaches a milestone with the issuance of the 100 millionth certified e-mail using its proprietary method

MADRID, Spain, June 05, 2023 (GLOBE NEWSWIRE) -- Lleida.net (OTC.US) (ALLLN.PA) (LLN.MA) issued its 100 millionth certified email last week, a milestone in the company's history.

Lleida.net reaches a milestone with the issuance of the 100 millionth certified e-mail using its proprietary method
VERSES, DENTONS US and SPATIAL WEB FOUNDATION To Release Industry Report Titled "A Path to Global AI Governance"

VANCOUVER, British Columbia, June 05, 2023 (GLOBE NEWSWIRE) -- VERSES AI Inc.  (CBOE CANADA:VERS) (OTCQX:VRSSF) ("VERSES'' or the "Company”), a cognitive computing company specializing in the next generation of...

VERSES, DENTONS US and SPATIAL WEB FOUNDATION To Release Industry Report Titled "A Path to Global AI Governance"
Shipping companies and supply chain showcase climate ambition ahead of critical climate negotiations

Oslo, Norway, June 05, 2023 (GLOBE NEWSWIRE) -- Leaders from the global shipping industry are taking action to align their businesses with what is needed to limit the worst impacts of climate change, according to those...

Shipping companies and supply chain showcase climate ambition ahead of critical climate negotiations
YGG SEA Rebrands to W3GG to Reflect Community-Driven Focus

NEW YORK, NY, June 04, 2023 (GLOBE NEWSWIRE) -- YGG team is thrilled to announce that YGG SEA, the exclusive official guild partner of Yield Guild Games in Southeast Asia, has officially changed its name to W3GG,...

YGG SEA Rebrands to W3GG to Reflect Community-Driven Focus
Chimeric Announces Launch of New Phase 1B Glioblastoma Clinical Trial

New CHM 1101 (CLXT CAR T) multi-center clinical trial activated at Sarah Cannon Research Institute (SCRI) in Austin, TexasEnrolment now open to patients with recurrent and/or progressive glioblastoma multiforme (GBM), the...

Chimeric Announces Launch of New Phase 1B Glioblastoma Clinical Trial
Bragar Eagel & Squire, P.C. Is Investigating Phathom, Reata, and Comerica and Encourages Investors to Contact the Firm

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT),...

Bragar Eagel & Squire, P.C. Is Investigating Phathom, Reata, and Comerica and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cutera, and Luminar and Encourages Investors to Contact the Firm

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of...

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cutera, and Luminar and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Is Investigating Relmada, Bowlero, and Integra and Encourages Investors to Contact the Firm

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Relmada Therapeutics, Inc. (NYSE: RLMD), Bowlero...

Bragar Eagel & Squire, P.C. Is Investigating Relmada, Bowlero, and Integra and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Is Investigating RH, Alvotech, and TriplePoint and Encourages Investors to Contact the Firm

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against RH (NYSE: RH), Alvotech (NASDAQ: ALVO), and...

Bragar Eagel & Squire, P.C. Is Investigating RH, Alvotech, and TriplePoint and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Virtu, TD, and Canopy and Encourages Investors to Contact the Firm

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of...

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Virtu, TD, and Canopy and Encourages Investors to Contact the Firm
PLUG ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Plug Power Inc. and Encourages Investors to Contact the Firm

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Plug Power Inc....

PLUG ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Plug Power Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against adidas, Spirit, and TDS and Encourages Investors to Contact the Firm

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of...

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against adidas, Spirit, and TDS and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Wheels Up, Horizon Bank, and LivePerson and Encourages Investors to Contact the Firm

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of...

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Wheels Up, Horizon Bank, and LivePerson and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stem, Disney, and Charles River and Encourages Investors to Contact the Firm

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of...

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stem, Disney, and Charles River and Encourages Investors to Contact the Firm
BEYOND MEAT ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Beyond Meat Inc. and Encourages Investors to Contact the Firm

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Beyond Meat Inc....

BEYOND MEAT ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Beyond Meat Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Trinseo, Edgio, and Fulcrum and Encourages Investors to Contact the Firm

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of...

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Trinseo, Edgio, and Fulcrum and Encourages Investors to Contact the Firm
ALLBIRDS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Allbirds, Inc. and Encourages Investors to Contact the Firm

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Allbirds, Inc....

ALLBIRDS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Allbirds, Inc. and Encourages Investors to Contact the Firm
FIRST REPUBLIC ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against First Republic Bank and Encourages Investors to Contact the Firm

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against First Republic Bank...

FIRST REPUBLIC ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against First Republic Bank and Encourages Investors to Contact the Firm
ICAHN ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Icahn Enterprises L.P. and Encourages Investors to Contact the Firm

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Icahn Enterprises...

ICAHN ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Icahn Enterprises L.P. and Encourages Investors to Contact the Firm
MPT ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Medical Properties Trust, Inc. and Encourages Investors to Contact the Firm

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Medical Properties...

MPT ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Medical Properties Trust, Inc. and Encourages Investors to Contact the Firm
Pathways names Evan Hyatt as President

Fort Collins, Colorado, June 04, 2023 (GLOBE NEWSWIRE) -- NEWS RELEASE FOR IMMEDIATE RELEASE June 1, 2023

Pathways names Evan Hyatt as President
Registration of share capital increase in IDEX Biometrics (Tranche 1) 3 Jun 2023

Reference is made to the notice on 24 May 2023 regarding completion a private placement of 147.1 million shares at NOK 0.85 per share in IDEX Biometrics ASA. The placement was split in two tranches of 116.9 million shares...

Registration of share capital increase in IDEX Biometrics (Tranche 1) 3 Jun 2023
Day One Announces New FIREFLY-1 Data for Tovorafenib (DAY101) and Initiation of Rolling NDA Submission to FDA for Relapsed or Progressive Pediatric Low-Grade Glioma

Overall response rate (ORR) of 67% and clinical benefit rate (CBR) of 93% in 69 heavily pretreated RANO-HGG evaluable patients

Day One Announces New FIREFLY-1 Data for Tovorafenib (DAY101) and Initiation of Rolling NDA Submission to FDA for Relapsed or Progressive Pediatric Low-Grade Glioma
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates APGN, KBNT, DM, WTT

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates APGN, KBNT, DM, WTT
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PTRS, RADI, NATI, REUN

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PTRS, RADI, NATI, REUN
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BACK, GNL, RTL

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BACK, GNL, RTL
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HMPT, VECT, PDCE, GHL

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HMPT, VECT, PDCE, GHL
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CHRA, ARNC, FRG

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CHRA, ARNC, FRG
Trilaciclib Increases Pool of Memory T Cells in the Tumor Microenvironment Responsible for Long Term Immune Surveillance and Efficacy

- Phase 2 Mechanism of Action Trial Results Demonstrate the Immunomodulatory Effects of Trilaciclib in the Tumor Microenvironment -

Trilaciclib Increases Pool of Memory T Cells in the Tumor Microenvironment Responsible for Long Term Immune Surveillance and Efficacy
Flash News: OKX Wallet Enables Participation in Chainge Finance's zkSync Event with New Partnership

SAN FRANCISCO, June 04, 2023 (GLOBE NEWSWIRE) -- OKX, the second-largest crypto platform by trading volume and a leading Web3 technology company, has issued updates for the day of June 4, 2023.

Flash News: OKX Wallet Enables Participation in Chainge Finance's zkSync Event with New Partnership
Evaxion's AI technology identifies cancer vaccine targets associated with longer progression-free survival of melanoma patients in the EVX-01 Phase 1 clinical trial

The clinical trial of the personalized cancer vaccine EVX-01 met its primary endpoints of safety and tolerabilityPositive clinical responses were reported in 8 out of 12 EVX-01 treated patientsHigh-quality neoantigens,...

Evaxion's AI technology identifies cancer vaccine targets associated with longer progression-free survival of melanoma patients in the EVX-01 Phase 1 clinical trial
Sutro Biopharma Announces Oral Presentation at ASCO 2023 Featuring Data for Luveltamab Tazevibulin from the Phase 1 Dose-Expansion Study in Ovarian Cancer and the Initiation of the Phase 2/3 Pivotal Study REFRaME-O1

- Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data from the Phase 1 dose-expansion study for luveltamab tazevibulin, or luvelta, in ovarian cancer, demonstrating that...

Sutro Biopharma Announces Oral Presentation at ASCO 2023 Featuring Data for Luveltamab Tazevibulin from the Phase 1 Dose-Expansion Study in Ovarian Cancer and the Initiation of the Phase 2/3 Pivotal Study REFRaME-O1
Replimune Presents RP1 Data from the IGNYTE anti-PD1 Failed Melanoma Cohort and RP2 Data in Uveal Melanoma at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Updated data from ongoing IGNYTE anti-PD1 failed melanoma cohort shows RP1 combined with nivolumab continues to demonstrate deep and durable responses with a well-tolerated safety profile; no progression in responding...

Replimune Presents RP1 Data from the IGNYTE anti-PD1 Failed Melanoma Cohort and RP2 Data in Uveal Melanoma at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
Cogent Biosciences Announces Positive Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluating Bezuclastinib in Combination with Sunitinib in Patients with Gastrointestinal Stromal Tumors (GIST)

-  Data presented at ASCO annual meeting demonstrate 55% Disease Control Rate (DCR) in heavily pre-treated GIST patients, including 100% DCR and 17% overall response rate (ORR) in efficacy evaluable 2nd-line GIST patients;...

Cogent Biosciences Announces Positive Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluating Bezuclastinib in Combination with Sunitinib in Patients with Gastrointestinal Stromal Tumors (GIST)
Ontarians say 'enough is enough' with day of action to fight cost-of-living crisis

TORONTO, June 03, 2023 (GLOBE NEWSWIRE) -- Today, thousands of workers and community members gathered for rallies across the province as part of the Ontario Federation of Labour’s Enough Is Enough Day of Action....

Ontarians say 'enough is enough' with day of action to fight cost-of-living crisis
CARIBBEAN AIRLINES LAUNCHES ITS SUSTAINABILITY PROGRAMME

The airline understands the importance of environmental, social, and governance (ESG)

CARIBBEAN AIRLINES LAUNCHES ITS SUSTAINABILITY PROGRAMME